We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
151
Xenon Pharmaceuticals
XENE
$6.12B
$986K 0.16%
25,000
– –
MUSA icon
152
Murphy USA
MUSA
$10.8B
$978K 0.16%
3,500
– –
CVLG icon
153
Covenant Logistics
CVLG
$900M
$968K 0.16%
56,000
– –
CAG icon
154
Conagra Brands
CAG
$7.09B
$968K 0.16%
25,000
– –
PLUG icon
155
Plug Power
PLUG
$2.97B
$965K 0.16%
78,000
– –
MET icon
156
MetLife
MET
$60.9B
$956K 0.15%
13,216
– –
KR icon
157
Kroger
KR
$35.1B
$936K 0.15%
21,000
– –
AZTA icon
158
Azenta
AZTA
$1.36B
$932K 0.15%
16,000
– –
BALL icon
159
Ball Corp
BALL
$16.8B
$921K 0.15%
18,000
– –
PLD icon
160
Prologis
PLD
$131B
$920K 0.15%
8,164
– –
TWI icon
161
Titan International
TWI
$468M
$919K 0.15%
60,000
– –
LTHM
162
DELISTED
Livent Corporation
LTHM
$914K 0.15%
46,000
– –
AEL
163
DELISTED
American Equity Investment Life Holding Company
AEL
$912K 0.15%
20,000
– –
CVCO icon
164
Cavco Industries
CVCO
$4.23B
$905K 0.15%
4,000
– –
TGT icon
165
Target
TGT
$67.2B
$894K 0.14%
6,000
– –
SRPT icon
166
Sarepta Therapeutics
SRPT
$1.69B
$894K 0.14%
6,900
– –
PDCE
167
DELISTED
PDC Energy, Inc.
PDCE
$889K 0.14%
14,000
– –
EQR icon
168
Equity Residential
EQR
$25.3B
$885K 0.14%
15,000
– –
TGTX icon
169
TG Therapeutics
TGTX
$7.14B
$859K 0.14%
72,600
– –
TRUP icon
170
Trupanion
TRUP
$1.08B
$856K 0.14%
18,000
– –
PACB icon
171
Pacific Biosciences
PACB
$447M
$818K 0.13%
100,000
– –
COF icon
172
Capital One
COF
$134B
$812K 0.13%
8,733
– –
HPQ icon
173
HP
HPQ
$24.9B
$806K 0.13%
30,000
– –
AX icon
174
Axos Financial
AX
$5.9B
$803K 0.13%
21,000
– –
CNXC icon
175
Concentrix
CNXC
$1.5B
$792K 0.13%
5,947
– –
5 6
7
8 9

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.